Huiyuan Li

Huiyuan Li

Auto-generated profile, based on publicly available information

Huiyuan Li

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2020 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
HLHuiyuan Li
Huiyuan Li
YGYue Guan
Yue Guan
BSBoyang Sun
Boyang Sun
XDXueqing Dou
Xueqing Dou
XLXiaofan Liu
Xiaofan Liu
RYRenchi Yang
Renchi Yang

18 May 2020 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
XZXian Zhang
Xian Zhang
YWYunlong Wang
Yunlong Wang
DZDonglei Zhang
Donglei Zhang
HLHuiyuan Li
Huiyuan Li
ZZZeping Zhou
Zeping Zhou
RYRenchi Yang
Renchi Yang

17 April 2017 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
MLMingen Lyu
Mingen Lyu
YHYating Hao
Yating Hao
YLYang Li
Yang Li
CLCuicui Lyu
Cuicui Lyu
WLWenjie Liu
Wenjie Liu
RYRenchi Yang
Renchi Yang

3 May 2017 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
HLHuiyuan Li
Huiyuan Li
YHYating Hao
Yating Hao
DZDonglei Zhang
Donglei Zhang
WLWenjie Liu
Wenjie Liu
YLYang Li
Yang Li
RYRenchi Yang
Renchi Yang

10 April 2023 in Thrombosis Research
Verified
Journal Article
Closed access
HDHuan Dong
Huan Dong
HLHuiyuan Li
Huiyuan Li
LFLijun Fang
Lijun Fang
AZAnqi Zhang
Anqi Zhang
XLXiaofan Liu
Xiaofan Liu
LZLei Zhang
Lei Zhang

1 August 2014 in DNA and Cell Biology
Verified
Journal Article
Open access
HLHuiyuan Li
Huiyuan Li
MXMin Xuan
Min Xuan
FXFeng Xue
Feng Xue
XLXiaofan Liu
Xiaofan Liu
DZDonglei Zhang
Donglei Zhang
RYRenchi Yang
Renchi Yang
Interleukin-18 (IL-18) is an inflammatory cytokine that plays an important role in autoimmune disease by inducing interferon-γ secretion. Considering the abnormal serum concentration of IL-18 in primary immune thrombocytopenia (ITP) patients and the regulated effect of IL-18 gene polymorphisms on its production, the aim of this study was to investigate a possible association between the IL-18 promoter polymorphisms (-137 G/C and -607 C/A sites) and genetic susceptibility to ITP in a Chinese Han population. A total of 181 ITP patients and 163 healthy controls were included in this study; IL-18 gene promoter polymorphisms were analyzed by a polymerase chain reaction with sequence-specific primers. No significant differences in genotype (-607: χ(2)=0.307, p=0.858; -137: χ(2)=0.378, p=0.828) and allele frequencies (-607: χ(2)=0.004, p=0.949; -137: χ(2)=0.307, p=0.858) were found between total ITP patients and normal controls. We further analyzed the association of IL-18 polymorphisms with clinical parameters of ITP patients, including first onset age and clinical therapy response to glucocorticoids, and no difference was revealed. In conclusion, IL-18 promoter polymorphisms may not be associated with genetic susceptibility to ITP in a Chinese Han population.